Polypharmacy definition and prevalence in heart failure: a systematic review.

Beezer, Janine; Al Hatrushi, Manal; Husband, Andy; Kurdi, Amanj; Forsyth, Paul

Beezer, Janine; Al Hatrushi, Manal; Husband, Andy; Kurdi, Amanj; Forsyth, Paul.

Beezer J; Inpatient Pharmacy Department, South Tyneside and Sunderland Foundation Trust (Pharmacy), Kayll Road, Sunderland, SR7 8DE, UK. janine.beezer@newcastle.ac.uk.
Al Hatrushi M; School of Pharmacy, Newcastle University, Newcastle, UK. janine.beezer@newcastle.ac.uk.
Husband A; Sultan Qaboos University Hospital (Pharmacy), Muscat, Oman.
Kurdi A; School of Pharmacy, Newcastle University, Newcastle, UK.
Forsyth P; Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow, UK.

Heart Fail Rev ; 27(2): 465-492, 2022 03.

Article en En | MEDLINE | ID: mdl-34213753

Asunto(s)

Insuficiencia Cardíaca; Polifarmacia; Adolescente; Comorbilidad; Insuficiencia Cardíaca/tratamiento farmacológico; Insuficiencia Cardíaca/epidemiología; Humanos; Prevalencia

Palabras clave

Heart failure; Medication; Multimorbidity; Polypharmacy; Prevalence

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polifarmacia / Insuficiencia Cardíaca Tipo de estudio: Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adolescent / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google